FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Goodman

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Geoffrey A Block; Glenn M Chertow; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T-Christian H Mix; Sharon M Moe; Marie-Louise Trotman; David C Wheeler; Patrick S Parfrey
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
Glenn M Chertow; Ricardo Correa-Rotter; Tilman B Drueke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T-Christian H Mix; Sharon M Moe; Geoffrey A Block; David C Wheeler; Patrick S Parfrey
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.
William G Goodman; L D Quarles
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Goodman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Geoffrey A Block; Glenn M Chertow; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T-Christian H Mix; Sharon M Moe; Marie-Louise Trotman; David C Wheeler; Patrick S Parfrey
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
The New England journal of medicine 2012;367(26):2482-94.
2012: Glenn M Chertow; Ricardo Correa-Rotter; Tilman B Drueke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T-Christian H Mix; Sharon M Moe; Geoffrey A Block; David C Wheeler; Patrick S Parfrey
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(7):2872-9.
2008: William G Goodman; L D Quarles
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
Kidney international 2008;74(3):276-88.
2007: Glenn M Chertow; Lara B Pupim; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drueke; Jürgen Floege; William G Goodman; Gerard M London; Kenneth W Mahaffey; Sharon M Moe; David C Wheeler; Moetaz B Albizem; Kurt Olson; Preston S Klassen; Patrick Parfrey
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(5):898-905.
2006: William G Goodman
Renal osteodystrophy for nonnephrologists.
Journal of bone and mineral metabolism 2006;24(2):161-3.
2005: Sharon M Moe; John Cunningham; Jürgen Bommer; Stephen Adler; Steven J Rosansky; Pablo Urena-Torres; Moetaz B Albizem; Matthew D Guo; Valter J Zani; William G Goodman; Stuart M Sprague
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2186-93.
2005: Kevin J Martin; Harald Jüppner; Donald J Sherrard; William G Goodman; Mark R Kaplan; George Nassar; Patricia Campbell; Mario Curzi; Chaim Charytan; Laura C McCary; Matthew D Guo; Stewart A Turner; David A Bushinsky
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl.
Kidney international 2005;68(3):1236-43.
2005: Isidro B Salusky; William G Goodman; Shobha Sahney; Barbara Gales; Ashley Perilloux; He-Jing Wang; Robert Elashoff; Harald Jüppner
Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
Journal of the American Society of Nephrology : JASN 2005;16(8):2501-8.
2005: William G Goodman
The evolution of assays for parathyroid hormone.
Seminars in dialysis 2005;18(4):296-301.
2005: William G Goodman
Calcimimetics: a remedy for all problems of excess parathyroid hormone activity in chronic kidney disease?
Current opinion in nephrology and hypertension 2005;14(4):355-60.
2005: William G Goodman
Calcium and phosphorus metabolism in patients who have chronic kidney disease.
The Medical clinics of North America 2005;89(3):631-47.
2005: Sharon M Moe; Glenn M Chertow; Jack W Coburn; L Darryl Quarles; William G Goodman; Geoffrey A Block; Tilman B Drüeke; John Cunningham; Donald J Sherrard; Laura C McCary; Kurt A Olson; Stewart A Turner; Kevin J Martin
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.
Kidney international 2005;67(2):760-71.
2004: William G Goodman
Calcimimetic agents for the treatment of secondary hyperparathyroidism.
Seminars in nephrology 2004;24(5):460-3.
2004: Randolph A Chen; William G Goodman
Role of the calcium-sensing receptor in parathyroid gland physiology.
American journal of physiology. Renal physiology 2004;286(6):F1005-11.
2004: William G Goodman
The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease.
Seminars in dialysis 2004;17(3):209-16.
2004: Geoffrey A Block; Kevin J Martin; A L M de Francisco; Stewart A Turner; Morrell M Avram; Michael G Suranyi; Gavril Hercz; John Cunningham; Ali Abu-Alfa; Piergiorgio Messa; Daniel W Coyne; Francesco Locatelli; Raphael M Cohen; Pieter Evenepoel; Sharon M Moe; Albert Fournier; Johann Braun; Laura C McCary; Valter J Zani; Kurt A Olson; Tilman B Drüeke; William G Goodman
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
The New England journal of medicine 2004;350(15):1516-25.
2004: William G Goodman
Importance of hyperphosphataemia in the cardio-renal axis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19 Suppl 1():i4-8.
2004: William G Goodman; Gerard London; Kerstin Amann; Geoffrey A Block; Cecilia M Giachelli; Keith A Hruska; Markus Ketteler; Adeera Levin; Ziad A Massy; David A McCarron; Paolo Raggi; Catherine Mary Shanahan; Noriaki Yorioka
Vascular calcification in chronic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(3):572-9.
2004: William G Goodman
Calcium-sensing receptors.
Seminars in nephrology 2004;24(1):17-24.
2003: William G Goodman
Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials.
Pediatric nephrology (Berlin, Germany) 2003;18(12):1206-10.
2003: William G Goodman
New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
Kidney international. Supplement 2003;(87):S120-4.
2003: William G Goodman
Medical management of secondary hyperparathyroidism in chronic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 3():iii2-8.
2003: Eleonora M Lima; William G Goodman; Beatriz D Kuizon; Barbara Gales; Aletha M Emerick; Jonathan G Goldin; Isidro B Salusky
Bone density measurements in pediatric patients with renal osteodystrophy.
Pediatric nephrology (Berlin, Germany) 2003;18(6):554-9.
2003: Isidro B Salusky; William G Goodman; Beatriz D Kuizon; Jeffrey R Lavigne; Richard J Zahranik; Barbara Gales; He-Jing Wang; Robert Elashoff; Harald Jüppner
Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Kidney international 2003;63(5):1801-8.
2003: William G Goodman
Assays for parathyroid hormone and their use in patients with end-stage renal disease.
Blood purification 2003;21(1):118-23.
2003: Jill S Lindberg; Sharon M Moe; William G Goodman; Jack W Coburn; Stuart M Sprague; Wei Liu; Peter W Blaisdell; Robert M Brenner; Stewart A Turner; Kevin J Martin
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Kidney international 2003;63(1):248-54.
2003: William G Goodman; Harald Jüppner; Isidro B Salusky; Donald J Sherrard
Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.
Kidney international 2003;63(1):1-11.
2002: William G Goodman
Vascular calcification in end-stage renal disease.
Journal of nephrology 2002;15 Suppl 6():S82-5.
2002: William G Goodman; Stewart A Turner
Future role of calcimimetics in end-stage renal disease.
Advances in renal replacement therapy 2002;9(3):200-8.
2002: Cheryl P Sanchez; Beatriz D Kuizon; William G Goodman; Barbara Gales; Robert Ettenger; M Ines Boechat; Yang Wang; Robert Elashoff; Isidro B Salusky
Growth hormone and the skeleton in pediatric renal allograft recipients.
Pediatric nephrology (Berlin, Germany) 2002;17(5):322-8.
2002: William G Goodman; Gerald Hladik; Stewart A Turner; Peter W Blaisdell; David A Goodkin; Wei Liu; Yousri M Barri; Raphael M Cohen; Jack W Coburn
The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.
Journal of the American Society of Nephrology : JASN 2002;13(4):1017-24.
2002: Isidro B Salusky; William G Goodman
Cardiovascular calcification in end-stage renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(2):336-9.
2001: Isidro B Salusky; William G Goodman
Adynamic renal osteodystrophy: is there a problem?
Journal of the American Society of Nephrology : JASN 2001;12(9):1978-85.
2001: William G Goodman
Calcimimetic agents for the treatment of hyperparathyroidism.
Current opinion in nephrology and hypertension 2001;10(5):575-80.
2001: William G Goodman; I B Salusky
Non-invasive assessments of cardiovascular disease in patients with renal failure.
Current opinion in nephrology and hypertension 2001;10(3):365-9.
2001: William G Goodman
Recent developments in the management of secondary hyperparathyroidism.
Kidney international 2001;59(3):1187-201.
2000: Isidro B Salusky; William G Goodman; Beatriz D Kuizon
Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism.
Pediatric nephrology (Berlin, Germany) 2000;14(7):641-5.
2000: William G Goodman; J M Frazao; D A Goodkin; Stewart A Turner; Wei Liu; Jack W Coburn
A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.
Kidney international 2000;58(1):436-45.
2000: William G Goodman; Jonathan G Goldin; Beatriz D Kuizon; Carol Yoon; Barbara Gales; D Sider; Y Wang; J Chung; Aletha M Emerick; L Greaser; Robert Elashoff; Isidro B Salusky
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.
The New England journal of medicine 2000;342(20):1478-83.
2000: Cheryl P Sanchez; Beatriz D Kuizon; P A Abdella; Harald Jüppner; Isidro B Salusky; William G Goodman
Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure.
Endocrinology 2000;141(4):1536-44.
1999: Cheryl P Sanchez; William G Goodman; Isidro B Salusky
Prevention of renal osteodystrophy in predialysis patients.
The American journal of the medical sciences 1999;317(6):398-404.
1999: Isidro B Salusky; William G Goodman; Beatriz D Kuizon
Consequences of intermittent calcitriol therapy in pediatric patients with secondary hyperparathyroidism.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1999;19 Suppl 2():S441-4.
1998: Cheryl P Sanchez; Isidro B Salusky; Beatriz D Kuizon; P Abdella; Harald Jüppner; William G Goodman
Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol.
Kidney international 1998;54(6):1879-87.
1998: Isidro B Salusky; Beatriz D Kuizon; TR Belin; J A Ramirez; Barbara Gales; G V Segre; William G Goodman
Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.
Kidney international 1998;54(3):907-14.
1998: William G Goodman; Johannes D Veldhuis; TR Belin; Andre J Van Herle; H Juppner; Isidro B Salusky
Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1998;83(8):2765-72.
1998: Cheryl P Sanchez; Isidro B Salusky; Beatriz D Kuizon; J A Ramirez; Barbara Gales; Robert Ettenger; William G Goodman
Bone disease in children and adolescents undergoing successful renal transplantation.
Kidney international 1998;53(5):1358-64.
1998: Beatriz D Kuizon; William G Goodman; Harald Jüppner; I Boechat; P Nelson; Barbara Gales; Isidro B Salusky
Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.
Kidney international 1998;53(1):205-11.
1997: William G Goodman; Johannes D Veldhuis; TR Belin; H Juppner; Isidro B Salusky
Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism.
Kidney international 1997;51(5):1590-5.
1996: Isidro B Salusky; William G Goodman
The management of renal osteodystrophy.
Pediatric nephrology (Berlin, Germany) 1996;10(5):651-3.
1996: Isidro B Salusky; William G Goodman
Parathyroid gland function in secondary hyperparathyroidism.
Pediatric nephrology (Berlin, Germany) 1996;10(3):359-63.
1996: Isidro B Salusky; William G Goodman
In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
Advances in nephrology from the Necker Hospital 1996;25():289-302.
1995: William G Goodman; Thomas R Belin; Barbara Gales; H Juppner; G V Segre; Isidro B Salusky
Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
Kidney international 1995;48(5):1553-8.
1995: Cheryl P Sanchez; William G Goodman; J A Ramirez; Barbara Gales; Thomas R Belin; G V Segre; Isidro B Salusky
Calcium-regulated parathyroid hormone secretion in adynamic renal osteodystrophy.
Kidney international 1995;48(3):838-43.
1995: Isidro B Salusky; William G Goodman
Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy.
Kidney international 1995;48(3):657-65.
1995: Cheryl P Sanchez; William G Goodman; D Brandli; M Goldenhersh; C Murray; E Carlton; T Hahn; Isidro B Salusky
Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(1):2-6.
1994: J A Ramirez; William G Goodman; Thomas R Belin; Barbara Gales; G V Segre; Isidro B Salusky
Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism.
The American journal of physiology 1994;267(6 Pt 1):E961-7.
1994: William G Goodman; J A Ramirez; Thomas R Belin; Y Chon; Barbara Gales; G V Segre; Isidro B Salusky
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
Kidney international 1994;46(4):1160-6.
1994: Isidro B Salusky; J A Ramirez; William Oppenheim; Barbara Gales; G V Segre; William G Goodman
Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
Kidney international 1994;45(1):253-8.
1993: C Messa; William G Goodman; Carl K Hoh; Y Choi; A R Nissenson; Isidro B Salusky; Michael E Phelps; R A Hawkins
Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry.
The Journal of clinical endocrinology and metabolism 1993;77(4):949-55.
1993: J A Ramirez; William G Goodman; J Gornbein; C Menezes; L Moulton; G V Segre; Isidro B Salusky
Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1993;76(6):1489-94.
1993: E P Boling; C Primavera; G Friedman; M King; L Bosserman; E E Schulz; William G Goodman
Non-invasive measurements of bone mass in adult renal osteodystrophy.
Bone 1993;14(3):409-13.
1993: J A Ramirez; William G Goodman; C Menezes; G V Segre; Isidro B Salusky
Disodium ethylenediaminetetraacetate: adverse effects in dialyzed children.
Pediatric nephrology (Berlin, Germany) 1993;7(2):182-4.
1991: Isidro B Salusky; J Foley; P Nelson; William G Goodman
Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
The New England journal of medicine 1991;324(8):527-31.
1991: William G Goodman; Isidro B Salusky
Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy.
Contributions to nephrology 1991;90():189-95.
1991: Jack W Coburn; Isidro B Salusky; Keith C Norris; William G Goodman
Oral and parenteral calcitriol for the management of end-stage renal disease.
Contributions to nephrology 1991;90():166-82.
1991: Isidro B Salusky; William G Goodman
Renal osteodystrophy in dialyzed children.
Mineral and electrolyte metabolism 1991;17(4):273-80.
1991: Isidro B Salusky; William G Goodman
Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis.
Child nephrology and urology 1991;11(3):165-8.
1990: Isidro B Salusky; William G Goodman; R Horst; G V Segre; L Kim; Keith C Norris; J S Adams; M Holloway; R N Fine; Jack W Coburn
Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1990;16(2):126-32.
1990: Isidro B Salusky; J W Coburn; P Nelson; William G Goodman
Prospective evaluation of aluminum loading from formula in infants with uremia.
The Journal of pediatrics 1990;116(5):726-9.
1989: J A Robertson; Isidro B Salusky; William G Goodman; Keith C Norris; Jack W Coburn
Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis.
Annals of internal medicine 1989;111(2):179-81.
1989: William Oppenheim; R Namba; William G Goodman; Isidro B Salusky
Aluminum toxicity complicating renal osteodystrophy. A case report.
The Journal of bone and joint surgery. American volume 1989;71(3):446-52.
1989: Isidro B Salusky; Judith E Brill; William Oppenheim; William G Goodman
Features of renal osteodystrophy in pediatric patients receiving regular peritoneal dialysis.
Seminars in nephrology 1989;9(1):37-42.
1986: Keith C Norris; William G Goodman; N Howard; M E Nugent; Jack W Coburn
Iliac crest bone biopsy for diagnosis of aluminum toxicity and a guide to the use of deferoxamine.
Seminars in nephrology 1986;6(4 Suppl 1):27-34.